Fundz

Chroma Dex Corp. reported raising $1 Million in an initial SEC Form D filing, from an offering of $1 Million

PUBLIC · NAGEMar 22, 2017

Amount Raised

$1 Million

$1 Million sold, per SEC Form D (first sale Mar 22, 2017)

Round Type

Seed

Los AngelesBiotechnologyHealth CareNutrition

Quick answer

Niagen Bioscience, Inc. raised $1 Million in a Seed round, dated March 22, 2017. Niagen Bioscience, Inc. is based in Los Angeles, California, United States.

How much did Niagen Bioscience, Inc. raise?
Niagen Bioscience, Inc. raised $1 Million in a Seed round on March 22, 2017.
What does Niagen Bioscience, Inc. do?
ChromaDex Corp. is a global bioscience company dedicated to healthy aging.
Where is Niagen Bioscience, Inc. based and how big is it?
Niagen Bioscience, Inc. is based in Los Angeles, California, United States.
Who are the decision-makers at Niagen Bioscience, Inc?
Fundz holds 1 contact at Niagen Bioscience, Inc., including the VP Qa/qo/pmo. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Nutrition and Biotechnology around the same time

Companies in the same sectors as Niagen Bioscience, Inc. that raised within 45 days of this round, from Fundz verified event records.

  • SPR Therapeutics raised $582K (Seed) on May 5, 2017.
  • Provention Bio raised $28M on May 4, 2017.
  • MED-X raised $12K on May 3, 2017.
  • Outset Medical raised $76M on May 3, 2017.
  • Route 92 Medical raised $5.9M on May 2, 2017.
  • Cocrystal Pharma, Inc. raised $3M (Seed) on May 2, 2017.

Who to call at Niagen Bioscience, Inc., and when

A new round usually means Niagen Bioscience, Inc. is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Niagen Bioscience, Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Niagen Bioscience, Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Niagen Bioscience, Inc.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Niagen Bioscience, Inc.

Location

10900 Wilshire Blvd

Los Angeles, California, United States

About

ChromaDex Corp. is a global bioscience company dedicated to healthy aging. The ChromaDex team, which includes world-renowned scientists, is pioneering research on nicotinamide adenine dinucleotide (NAD+), levels of which decline with age. ChromaDex is the innovator behind NAD+ precursor nicotinamide riboside (NR), commercialized as the flagship ingredient Niagen®. Nicotinamide riboside and other NAD+ precursors are protected by ChromaDex’s patent portfolio.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Niagen Bioscience, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsAlbert R., VP Qa/qo/pmo hidden hidden hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Niagen Bioscience, Inc.'s next move

See what Strategic adds

Niagen Bioscience, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.